RankingsPricing
  1. US-listed companies
  2. ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.NDRA

Market cap
$1.93M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Research and development-----7
Sales and marketing-----1
General and administrative-----5
Total operating expenses-----13
Operating loss------13,157,559
Gain on extinguishment of debt----308,600-
Other income (expense)------21,533
Total other expenses------21,533
Loss from operations before income taxes------13,179,092
Net Loss-5,376,962-9,796,261-13,305,964-11,725,5011113
Deemed dividend--4395,551121,071-
Net Loss attributable to common stockholders------13,179,092
Net loss per share - basic and diluted------4.56